Search

Your search keyword '"Witzel I"' showing total 321 results

Search Constraints

Start Over You searched for: Author "Witzel I" Remove constraint Author: "Witzel I"
321 results on '"Witzel I"'

Search Results

1. Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer

2. Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers

6. Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force

9. 208P Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases: A subanalysis of the German brain metastases in breast cancer registry (BMBC)

13. Long-term survival of HER2-positive breast cancer patients with brain metastases: subanalysis of the BMBC Registry

15. 269P Long-term survival of HER2-positive breast cancer patients with brain metastases: Subanalysis of the BMBC registry

16. 151P Tumor biology and immunology in patients (pts) with breast cancer occurring during pregnancy (BCP) compared to non-pregnant breast cancer pts

17. Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC Registry

18. 170P Long-term survival of breast cancer patients with brain metastases: Subanalysis of the BMBC registry

19. Long-term survival of HER2-positive breast cancer patients with brain metastases: Subanalysis of the BMBC registry

20. Long-term survival of breast cancer patients with brain metastases: Subanalysis of the BMBC registry

24. Characteristics of patients with brain metastases from HER2-positive breast cancer

25. 95MO Characteristics of patients with brain metastases from HER2-positive breast cancer

26. Characteristics of patients with brain metastases from HER2-positive breast cancer

28. Clinical-pathological Characterization of 1078 Advice Seekers with pathogenic CHEK2 Mutation from the German Consortium of Familial Breast and Ovarian Cancer (DK-FBREK)

29. 44O Pembrolizumab (pembro) vs chemotherapy (chemo) for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-119 Asia-Pacific subpopulation

32. Charakteristika und Überlebensanalyse der Patienten mit asymptomatischen Hirnmetastasen eines Mammakarzinoms

34. Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry – comparison of three different prognostic scores

35. Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system

36. Characteristics and clinical outcome of breast cancer patients with asymptomatic brain metastases

38. Klinisch-pathologische Charakterisierung von 1078 Ratsuchenden mit pathogener CHEK2 Mutation aus dem Deutschen Konsortium Familiärer Brust- und Eierstockkrebs (DK-FBREK)

40. 149P Predicting prognosis of breast cancer patients with brain metastases in the BMBC registry: Comparison of three different prognostic scores

44. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

45. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

46. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

48. KEYNOTE-119: Phase III study of pembrolizumab (pembro) versus single-agent chemotherapy (chemo) for metastatic triple negative breast cancer (mTNBC)

49. PRECYCLE: Impact of CANKADO-based eHealth-support on quality of life in metastatic breast cancer patients treated with palbociclib and endocrine therapy

Catalog

Books, media, physical & digital resources